Evidence map›Paper›PMID 38260897›Full record

SynthesisFrontiers in microbiology2023

A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome.

Zishuai Liu, Zhouling Jiang, Ligang Zhang, Xiaoyu Xue, Chenxi Zhao, Yanli Xu, Wei Zhang, Ling Lin, Zhihai Chen

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Severe fever thrombocytopenia syndrome proceeding east.Journal of rural medicine : JRM · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zishuai Liu *Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhouling Jiang *Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Ligang Zhang *Department of Infectious Diseases, Yantai Qishan Hospital, Yantai, China.
Xiaoyu XueDepartment of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Chenxi ZhaoDepartment of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yanli XuDepartment of Infectious Diseases, Yantai Qishan Hospital, Yantai, China.
Wei ZhangDepartment of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Ling LinDepartment of Infectious Diseases, Yantai Qishan Hospital, Yantai, China.
Zhihai ChenDepartment of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Ditan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early identification of risk factors associated with poor prognosis in Severe fever with thrombocytopenia syndrome (SFTS) patients is crucial to improving patient survival. Method: Retrieve literature related to fatal risk factors in SFTS patients in the database, extract the risk factors and corresponding RRs and 95% CIs, and merge them. Statistically significant factors were included in the model, and stratified and assigned a corresponding score. Finally, a validation cohort from Yantai Qishan Hospital in 2021 was used to verify its predictive ability. Result: A total of 24 articles were included in the meta-analysis. The model includes six risk factors: age, hemorrhagic manifestations, encephalopathy, Scr and BUN. The analysis of lasso regression and multivariate logistic regression shows that model score is an independent risk factor (OR = 1.032, 95% CI 1.002-1.063, Conclusion: The prediction model for the fatal outcome of SFTS patients has shown positive outcomes.

Indexed as

cohort studymeta-analysisprediction modelrisk factorsSFTS

Identifiers

PMID38260897
PMCPMC10801726
OpenAlexW4390663328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.